With the aim to add a “revenue generating CDMO arm,” Lantheus Holdings has bought New Jersey-based radiopharmaceutical company Evergreen Theragnostics.

Such growth makes China an increasingly important player in the global biopharmaceutical industry, offering potential market ...

BPI is poised to enter its 23rd year in print. The 21st century has brought many changes to publishing(e.g., from online presence as a “value-add” to an essential) but throughout the decades, some ...

The Cydem VT system combines multiple trusted Beckman Coulter Life Sciences technologies into one advanced platform that empowers lab managers with a far more effective, higher-throughput method for ...

Founded in the middle of 2002, BPI published its first issue in January of 2003. Our 20th-anniversary issue thus takes the form of a state-of-the-early-21st-century industry report. Assembling this ...

Biotechnology company Amgen is building a $1 billion drug substance manufacturing facility in Holly Springs, North Carolina, expanding its presence in the region with its second such facility. In ...

Industry will see mid-teens grams/L of product within five years but downstream processes are the big ‘virgin territory’ for further productivity gains, says Avantor’s Ger Brophy. In the aftermath of ...

Happy 2022 to all of BPI’s loyal and supportive authors, readers, and advertisers. Despite continuing pandemic impediments, your industry continues to show remarkable flexibility and resilience. As ...

Scientific advances have increased the safety and efficacy of recombinant viral-vector technology for cell and gene therapies. In this special report, we will discuss how tailored transfection ...